90 studies found for:    "GRN-related frontotemporal dementia" OR "Frontotemporal Dementia"
Show Display Options
Rank Status Study
21 Completed
Has Results
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
Condition: Niemann-Pick Disease, Type C
Intervention: Drug: N-Acetyl Cysteine
22 Recruiting Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Conditions: FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
Intervention:
23 Recruiting Communication Bridge Speech Therapy Research Study
Conditions: Primary Progressive Aphasia;   Alzheimer's Disease;   Frontotemporal Dementia
Intervention: Behavioral: Monthly Check-in Session
24 Completed Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment;   Vascular Dementia;   Fronto-temporal Dementia;   Primary Progressive Aphasia;   Parkinson' Disease Dementia;   Mixed Dementia
Intervention:
25 Recruiting Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
Condition: Neimann-Pick Disease, Type C
Intervention:
26 Not yet recruiting A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C
Condition: Niemann-Pick Disease, Type C
Intervention:
27 Completed Treatment Study of Frontotemporal Dementia
Condition: Frontotemporal Lobar Degeneration
Intervention:
28 Unknown  Effects of Tolcapone on Frontotemporal Dementia
Condition: Frontotemporal Lobar Degeneration
Intervention: Drug: Tolcapone
29 Terminated Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
Conditions: Acid Sphingomyelinase Deficiency;   Niemann-Pick Disease
Intervention: Drug: rhASM
30 Recruiting Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease
Condition: Niemann-Pick Disease, Type C1
Intervention: Drug: 2-hydroxypropyl-beta-cyclodextrin
31 Completed Language Treatment for Progressive Aphasia
Conditions: Primary Progressive Aphasia;   Nonfluent Progressive Aphasia;   Semantic Dementia
Intervention: Behavioral: Errorless learning
32 Recruiting Genetics of Familial and Sporadic ALS
Conditions: Amyotrophic Lateral Sclerosis;   Familial Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis and Frontotemporal Dementia;   Lou Gehrig's Disease;   Motor Neuron Disease;   Primary Lateral Sclerosis
Intervention: Other: Genetic study of ALS families
33 Recruiting Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family
Conditions: Frontotemporal Dementia;   Alzheimer's Disease.
Intervention:
34 Active, not recruiting Computational Tools for Early Diagnosis of Memory Disorders
Conditions: Alzheimer Disease;   Frontotemporal Dementia;   Dementia, Vascular;   Mild Cognitive Impairment
Intervention:
35 Enrolling by invitation A Composite MR Neuroimaging Marker for Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment;   Frontotemporal Dementia
Intervention:
36 Terminated Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)
Condition: Dementia
Intervention: Drug: amantadine
37 Completed Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
Condition: Dementia
Intervention: Drug: memantine
38 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
39 Recruiting Biomarker for Niemann Pick Type C Disease
Conditions: Niemann-Pick Disease;   Niemann-Pick Disease, Type C
Intervention:
40 Terminated
Has Results
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Conditions: Hurler's Syndrome;   Maroteaux-Lamy Syndrome;   Sly Syndrome;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Sphingolipidoses;   Krabbe Disease;   Wolman's Disease;   Niemann-Pick Disease Type B;   Niemann-Pick Disease, Type C
Interventions: Procedure: Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Campath-1H;   Drug: Busulfan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years